Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
Since that time more than 800k activations were made and 234 MEUR spent (as of 2024)
Liposome l nhng phn t hnh cu siu nh c cu to tng t nh mng t bo trong c th chng ta
Naltrexone-Bupropion, 30%
US$ 21.34
US$ 24.27
US$ 29.67
US$ 21.86
US$ 27.91
US$ 22.54
